Figure 4From: Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging studyDose–response plot of urinary LTE 4 . Ratio of mean change from baseline in urinary LTE4. Error bars represent 95% confidence interval. LS = least squares.Back to article page